Consumer price index by country

Government of Canada continues to deliver on more affordable telecom services

Retrieved on: 
Friday, March 10, 2023
CRTC, The Honourable, Innovation, Science and Economic Development Canada, Canadian Radio-television and Telecommunications Commission, Government, Consumer, Statistics Canada, Telecommunications, Annual report, Economic development, Consumer price index by country, Local government in Canada, Policy, Mobile phone, Internet service provider, Innovation, Science

OTTAWA, ON, March 10, 2023 /CNW/ - The Government of Canada is making every effort to ensure that telecommunications services are reliable, innovative, competitive and—most crucially—affordable.

Key Points: 
  • OTTAWA, ON, March 10, 2023 /CNW/ - The Government of Canada is making every effort to ensure that telecommunications services are reliable, innovative, competitive and—most crucially—affordable.
  • Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced the publication of the 2022 Price Comparison Study of Telecom Services , an annual report that tracks the prices for wireless and home Internet services.
  • More work must be done and that's why the government continues to advance policies that prioritize competition, which in turn will drive down prices and make services more affordable for Canadians.
  • It's clear from this study that competition is key to further reducing prices, and our government will continue to pursue the policies necessary to increase consumer choice for telecom services across Canada."

EQS-News: CBOE's Weekly Market Recap: Nov.14-18 – Biogen’s Alzheimer’s Drug Captures Investors’ Attention

Retrieved on: 
Sunday, November 27, 2022
Invesco, BIT, CPI, Producer, IShares, CBOE, EPA, ETF, Biotechnology, Biogen, Consumer price index by country, Federal, Consumer, VIX, BATS, LSE, UCITS, Cboe Global Markets, Chicago, BIIB, QQQ, Société Générale, CAC, ISF, Wall, BTC, IWM, Clinical trial, SPDR, Eye, FDA, PPI, Security (finance), Financial adviser, Cryptocurrency, Birth control, Fashion, Poultry, Bitcoin, Solana, Ethereum

With uncertainty brimming, Cboe highlights Biogen Inc. (NASDAQ: BIIB) as a chart that may have piqued investor interest following positive clinical trial results for their new Alzheimers drug.

Key Points: 
  • With uncertainty brimming, Cboe highlights Biogen Inc. (NASDAQ: BIIB) as a chart that may have piqued investor interest following positive clinical trial results for their new Alzheimers drug.
  • Cboe has compiled a list of earnings for investors to keep an eye on at the bottom of this report.
  • Shares of Biogen skyrocketed on Sept. 22nd after the company announced positive clinical trial results for their Alzheimers drug lecanemab.
  • These results have brought Biogen closer to a Federal Drug Agency (FDA) approved Alzheimers drug, a feat several biopharmaceutical companies are competing to achieve.